<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04911296</url>
  </required_header>
  <id_info>
    <org_study_id>CP-0003</org_study_id>
    <nct_id>NCT04911296</nct_id>
  </id_info>
  <brief_title>Pill Swallow Study</brief_title>
  <official_title>Pill Swallow Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RANI Therapeutics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RANI Therapeutics</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective, single-center, open-label, single-arm, observational study assessing&#xD;
      participant experience with swallowing the Mock-RP&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2021</start_date>
  <completion_date type="Actual">August 27, 2021</completion_date>
  <primary_completion_date type="Actual">August 27, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percent of participants successfully swallowing the Mock-RP as reported on the questionnaire.</measure>
    <time_frame>Immediately after swallowing</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Assess if participant would choose a pill instead of their current injection therapy if a pill becomes available.</measure>
    <time_frame>Immediately after swallowing</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Participant experience with swallowing Mock-RP stratified by number of years using injections.</measure>
    <time_frame>Immediately after swallowing</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Participant experience with swallowing Mock-RP stratified by age (21-50, 51-65, 66-75 years).</measure>
    <time_frame>Immediately after swallowing</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Participant experience with swallowing Mock-RP stratified by frequency of injection treatment.</measure>
    <time_frame>Immediately after swallowing</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>All adverse events categorized by type and frequency.</measure>
    <time_frame>Immediately after swallowing</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">152</enrollment>
  <condition>Not Determined</condition>
  <arm_group>
    <arm_group_label>Swallow Group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Mock-RP</intervention_name>
    <description>Standard 000 capsule filled with potato starch, enteric-coated with colorant and lubricious coating.</description>
    <arm_group_label>Swallow Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Participant age is 21 - 75 years&#xD;
&#xD;
          2. Participant understands the nature of the study, is willing to comply with protocol&#xD;
             defined evaluations, and provide written informed consent&#xD;
&#xD;
          3. Participant currently taking injections to treat a chronic disorder&#xD;
&#xD;
          4. Non-pregnant, non-lactating female NOTE: Females who are of childbearing potential&#xD;
             must have had a negative pregnancy test on day of screening&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Active case of COVID-19&#xD;
&#xD;
          2. History of Dysphagia&#xD;
&#xD;
          3. History of dementia (e.g., Alzheimer's, vascular dementia, dementia with Lewy bodies,&#xD;
             etc.)&#xD;
&#xD;
          4. Participant self-reports issues with swallowing pills.&#xD;
&#xD;
          5. History of drug or alcohol abuse or any other factor that, in the Investigator's&#xD;
             opinion, may interfere with the participant's ability to cooperate and comply with the&#xD;
             study procedures&#xD;
&#xD;
          6. History of allergic reaction to a component of the Mock-RP&#xD;
&#xD;
          7. History which, in the investigator's judgement, makes the participant ineligible or&#xD;
             exposes the participant to unacceptable risks&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Clinical Trials of Texas</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>May 27, 2021</study_first_submitted>
  <study_first_submitted_qc>June 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 3, 2021</study_first_posted>
  <last_update_submitted>September 15, 2021</last_update_submitted>
  <last_update_submitted_qc>September 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

